FDA 483 - Concert Medical, LLC - March 05, 2020

An FDA inspection of Concert Medical, LLC, a manufacturer of coronary guidewires in Norwell, MA, identified a significant quality system deficiency. The firm failed to adequately establish and follow procedures for controlling environmental conditions. Specifically, their SOP for timely completion of cleaning and maintenance logs in a controlled environment room was not followed during manufacturing.